A structure-based drug design approach for the identification of antiviral compounds targeting the chikungunya virus RdRp protein
There are an estimated 3 million Chikungunya virus (CHIKV) infections per year, but no vaccines or specific pharmaceutical treatments are available. RNA-dependent RNA polymerase (RdRp) of CHIKV, encoded by nonstructural protein 4 (nsP4), was targeted to identify potential antiviral compounds in this...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Chemical Physics Impact |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266702242300289X |